• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

What’s New in COPD? A Recap of 7 Key Studies for Primary Care

Article

COPD gets an early start, jury still out on nocturnal oxygen, breath test could distinguish COVID-19—scroll through these slides for concise summaries of the latest research findings.

Chronic obstructive pulmonary disease (COPD) gets an early start, jury still out on nocturnal oxygen, breath test could distinguish coronavirus disease 2019 (COVID-19)—as year’s end approaches, these and other developments headline the latest news in COPD research.

Scroll through the slides below for concise summaries of the latest findings.

Recent Videos
Related Content
©vinnstock/Shutterstock.com

Antivirals for Influenza Underutilized Among Vulnerable Children, Adolescents

Grace Halsey
November 20th 2024
Article

Analysis of surveillance data revealed a decline in use of antiviral medications for children hospitalized with influenza and prevalent underprescribing in outpatient settings.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Awareness of Lung Cancer Screening Extremely Low Among Those at Highest Risk in the US: New Data /image credit Gerard Silvestri, MD, MS, courtesy of Hollings Cancer Center

Awareness of Lung Cancer Screening Extremely Low Among Those at Highest Risk in the US: New Data

Grace Halsey
November 18th 2024
Article

Among current smokers, 71% had never spoken a clinician about screening and among those who had quit, 75% had never had a conversation.

FDA Accepts Dupilumab sBLA for Review for Treatment of Chronic Spontaneous Urticaria / Image credit: ©chomplearn 2001/AdobeStock

FDA Accepts Dupilumab sBLA for Review for Treatment of Chronic Spontaneous Urticaria

Sydney Jennings
November 15th 2024
Article

The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Sydney Jennings
November 11th 2024
Article

Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.

FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products

FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products

Grace Halsey
November 8th 2024
Article

A decision on ending use of oral phenylephrine as a nasal decongestant in OTC products will be made following public comment on FDA's proposed order.

© 2024 MJH Life Sciences

All rights reserved.